| pubmed-article:3080505 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3080505 | lifeskim:mentions | umls-concept:C0020792 | lld:lifeskim |
| pubmed-article:3080505 | lifeskim:mentions | umls-concept:C0038412 | lld:lifeskim |
| pubmed-article:3080505 | lifeskim:mentions | umls-concept:C0597357 | lld:lifeskim |
| pubmed-article:3080505 | lifeskim:mentions | umls-concept:C0001804 | lld:lifeskim |
| pubmed-article:3080505 | lifeskim:mentions | umls-concept:C0442040 | lld:lifeskim |
| pubmed-article:3080505 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:3080505 | pubmed:dateCreated | 1986-3-20 | lld:pubmed |
| pubmed-article:3080505 | pubmed:abstractText | The objective of this study was to characterize a fraction from oral streptococci containing receptor activity for salivary agglutinin molecules. Several species and strains of streptococci were disrupted in a Ribi press. The supernatant was nuclease-treated and subjected to differential centrifugation. Receptor activity in the fractions was measured by the inhibition of saliva-mediated bacterial aggregation. In addition, bacterial strains were tested for their ability to aggregate and to deplete saliva of agglutinin activity. Three patterns of activity were observed: Streptococcus sanguis M5 depleted saliva of agglutinin activity and aggregated well; Streptococcus sanguis CC5A depleted saliva of agglutinin but did not aggregate well; and Streptococcus faecalis S-161 neither depleted saliva of agglutinin nor did it aggregate. The 105,000 g supernatant fractions derived from Ribi-disrupted Streptococcus sanguis M5 and CC5A, but not from Streptococcus faecalis, showed dose-dependent inhibition of saliva-mediated aggregation. This inhibitory activity was non-dialyzable, had the same heat and trypsin sensitivity as that seen with intact bacteria, and was not due to enzymatic digestion of the salivary agglutinin. Iso-electric focusing revealed a single active region with a pI of 5.5 which was clearly separated from the bulk of the bacterial proteins. | lld:pubmed |
| pubmed-article:3080505 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3080505 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3080505 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3080505 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3080505 | pubmed:citationSubset | D | lld:pubmed |
| pubmed-article:3080505 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3080505 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3080505 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3080505 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3080505 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3080505 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3080505 | pubmed:month | Feb | lld:pubmed |
| pubmed-article:3080505 | pubmed:issn | 0022-0345 | lld:pubmed |
| pubmed-article:3080505 | pubmed:author | pubmed-author:MalamudDD | lld:pubmed |
| pubmed-article:3080505 | pubmed:author | pubmed-author:GolubE EEE | lld:pubmed |
| pubmed-article:3080505 | pubmed:author | pubmed-author:RobinovitchM... | lld:pubmed |
| pubmed-article:3080505 | pubmed:author | pubmed-author:LancyPPJr | lld:pubmed |
| pubmed-article:3080505 | pubmed:author | pubmed-author:RosanBB | lld:pubmed |
| pubmed-article:3080505 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3080505 | pubmed:volume | 65 | lld:pubmed |
| pubmed-article:3080505 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3080505 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3080505 | pubmed:pagination | 98-104 | lld:pubmed |
| pubmed-article:3080505 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:meshHeading | pubmed-meshheading:3080505-... | lld:pubmed |
| pubmed-article:3080505 | pubmed:year | 1986 | lld:pubmed |
| pubmed-article:3080505 | pubmed:articleTitle | Identification of a Streptococcus sanguis receptor for salivary agglutinins. | lld:pubmed |
| pubmed-article:3080505 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3080505 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3080505 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3080505 | lld:pubmed |
